Epoch 36: Tough Times in the Biopharma Job Market

Hiring Outlook, Compensation Outlook, Length of Job Searches

Hello Avatar! Welcome back for another week of biotech analysis. Today is Sunday, which means this is our Building Biotech newsletter that is focused on discussing biopharma strategy topics. Today, we will discuss the significant challenges and changes that have shaped the biopharma industry in the first half of 2024. The sector has faced widespread layoffs, a tightening job market, and evolving compensation expectations, prompting both employers and professionals to reassess their strategies. As unemployment periods extended, many individuals—both unemployed and employed—began lowering their salary expectations in response to fierce competition. Simultaneously, employers, grappling with economic uncertainties and rising demands, have been forced to adopt more conservative approaches to salary budgets. Despite these hurdles, there remains a sense of cautious optimism among job seekers, and the industry is in a state of flux as both companies and professionals navigate this complex landscape. By understanding these trends, we can better prepare for the future, ensuring strategic decision-making that fosters resilience and competitiveness in an ever-changing environment.

If you're not subbed yet click the link below.  Every Thursday we are out with our FREE public/private biotech market update. Sundays are the days we focus on forward looking strategy.  Monday’s are for public equity research.  Tomorrow we will focus on C4 Therapeutics is set to share CFT-1946 BRAF V600X Phase 1 dose escalation data in NSCLC, CRC & melanoma. With options pricing indicating an astounding 60% volatility, the market is bracing for significant movement. Keep a close eye on this one, as it represents a major milestone in the degrader space.

Please help spread the work by subscribing and hitting the share button if you are enjoying our bi-weekly newsletters!

Enough shilling for the day, lots to cover this week, let's get started!

As a back drop to today’s discussion we will not the the Labor Department recently revised down the number of jobs added by >800k! We have been screaming about the inconsistency in data not matching what we are seeing on the ground for a year now and it turns out we were correct. Things are not good, we all know it - lets dig into data to quantitate the situation.